Multifunctional DNA nano-sponge system for targeted sensitization of ovarian cancer chemotherapy via metabolic reprogramming and ferroptosis induction

Dong Kejun & Xiao Xianjin et al. · 2025-03-28

12Citations
The inefficacy of chemotherapy in ovarian cancer, hindered by poor targeting and multiple drug resistance, is intricately linked to the tumor micro-environment and abnormal metabolic patterns. Here, we present ZnO
TL;DR

In vitro and in vivo studies demonstrate that ZnOov@DS-DOX effectively modulates tumor metabolic pathways, mitigates drug resistance, and enhances treatment outcomes, representing a significant advancement in nanomedicine and cancer therapy.

AI-generated by Semantic Scholar

Authors
Dong Kejun, Hu Hao, Cheng Shuangshuang, Mu Yaoqin, Zhang Wei, Zhou Ting, Zhang Jiarui, Shu Wan, Shen Xiaoyu, Wang Hongbo, Xiao Xianjin